Search research articles
Contact Us
Filters
Showing results (161-170 of 262) with videos related to
Page
of 27
Sort By:
The Journal of Rheumatology
|
April 15, 2026
Remission rates and predictors in idiopathic inflammatory myopathy subgroups: Insights from a single-center cohort
Nantakarn Pongtarakulpanit, Sidra Tahir, Varshapriya Suresh, et al.
The Journal of Rheumatology
|
March 3, 2015
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group
Dinesh Khanna, Shikha Mittoo, Rohit Aggarwal, et al.
Clinical and Experimental Rheumatology
|
January 5, 2024
Serum cytokine profiles of adults with idiopathic inflammatory myopathies
Didem Saygin, Partha S Biswas, Seyed Mehdi Nouraie, et al.
Clinical, Cosmetic and Investigational Dermatology
|
June 11, 2026
Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
Rohit Aggarwal, Elena Peeva, David Franklin Fiorentino, et al.
Seminars in Arthritis and Rheumatism
|
March 4, 2026
Nomenclature and abbreviation heterogeneity in immune-mediated necrotizing myopathy: A call for standardization
Maha Almackenzie, Niladri Bhowmick, Ganeev Bhangoo, et al.
Arthritis Care & Research
|
March 18, 2015
Distinctions between diagnostic and classification criteria?
Rohit Aggarwal, Sarah Ringold, Dinesh Khanna, et al.
The Journal of Rheumatology
|
August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms
Lisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
BMC Pulmonary Medicine
|
October 31, 2024
Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease
Rohit Aggarwal, Chester V Oddis, Daniel I Sullivan, et al.
Clinical and Experimental Rheumatology
|
October 9, 2015
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab
Consuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Rheumatology (Oxford, England)
|
February 7, 2025
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study
Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 262) with videos related to
Sort By:
Page
of 27
The Journal of Rheumatology
|
April 15, 2026
Remission rates and predictors in idiopathic inflammatory myopathy subgroups: Insights from a single-center cohort
Nantakarn Pongtarakulpanit, Sidra Tahir, Varshapriya Suresh, et al.
The Journal of Rheumatology
|
March 3, 2015
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group
Dinesh Khanna, Shikha Mittoo, Rohit Aggarwal, et al.
Clinical and Experimental Rheumatology
|
January 5, 2024
Serum cytokine profiles of adults with idiopathic inflammatory myopathies
Didem Saygin, Partha S Biswas, Seyed Mehdi Nouraie, et al.
Clinical, Cosmetic and Investigational Dermatology
|
June 11, 2026
Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
Rohit Aggarwal, Elena Peeva, David Franklin Fiorentino, et al.
Seminars in Arthritis and Rheumatism
|
March 4, 2026
Nomenclature and abbreviation heterogeneity in immune-mediated necrotizing myopathy: A call for standardization
Maha Almackenzie, Niladri Bhowmick, Ganeev Bhangoo, et al.
Arthritis Care & Research
|
March 18, 2015
Distinctions between diagnostic and classification criteria?
Rohit Aggarwal, Sarah Ringold, Dinesh Khanna, et al.
The Journal of Rheumatology
|
August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms
Lisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
BMC Pulmonary Medicine
|
October 31, 2024
Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease
Rohit Aggarwal, Chester V Oddis, Daniel I Sullivan, et al.
Clinical and Experimental Rheumatology
|
October 9, 2015
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab
Consuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Rheumatology (Oxford, England)
|
February 7, 2025
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study
Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Page
of 27